BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1073 related articles for article (PubMed ID: 26701127)

  • 1. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Expression of IL-36 Family Members and IL-38 by Immune and Nonimmune Cells in Patients with Active Inflammatory Bowel Disease.
    Fonseca-Camarillo G; Furuzawa-Carballeda J; Iturriaga-Goyon E; Yamamoto-Furusho JK
    Biomed Res Int; 2018; 2018():5140691. PubMed ID: 30643810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium.
    Frey S; Derer A; Messbacher ME; Baeten DL; Bugatti S; Montecucco C; Schett G; Hueber AJ
    Ann Rheum Dis; 2013 Sep; 72(9):1569-74. PubMed ID: 23268368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The severity of imiquimod-induced mouse skin inflammation is independent of endogenous IL-38 expression.
    Palomo J; Troccaz S; Talabot-Ayer D; Rodriguez E; Palmer G
    PLoS One; 2018; 13(3):e0194667. PubMed ID: 29554104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.
    Zhao Z; Zhang R; Gao X; Li H; Liu H
    Medicine (Baltimore); 2020 Dec; 99(52):e23832. PubMed ID: 33350771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology of IL-36 cytokines and their role in disease.
    Gresnigt MS; van de Veerdonk FL
    Semin Immunol; 2013 Dec; 25(6):458-65. PubMed ID: 24355486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
    Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
    Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the novel IL-1 family cytokines by QAH-IL1F-1 assay in rheumatoid arthritis.
    Wang M; Wang B; Ma Z; Sun X; Tang Y; Li X; Wu X
    Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(4):31-4. PubMed ID: 27188731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.
    Athari SK; Poirier E; Biton J; Semerano L; Hervé R; Raffaillac A; Lemeiter D; Herbelin A; Girard JP; Caux F; Boissier MC; Bessis N
    Arthritis Res Ther; 2016 Jun; 18(1):143. PubMed ID: 27317338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-37 Alleviates Rheumatoid Arthritis by Suppressing IL-17 and IL-17-Triggering Cytokine Production and Limiting Th17 Cell Proliferation.
    Ye L; Jiang B; Deng J; Du J; Xiong W; Guan Y; Wen Z; Huang K; Huang Z
    J Immunol; 2015 Jun; 194(11):5110-9. PubMed ID: 25917106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unprocessed Interleukin-36α Regulates Psoriasis-Like Skin Inflammation in Cooperation With Interleukin-1.
    Milora KA; Fu H; Dubaz O; Jensen LE
    J Invest Dermatol; 2015 Dec; 135(12):2992-3000. PubMed ID: 26203636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation.
    Corvaisier M; Delneste Y; Jeanvoine H; Preisser L; Blanchard S; Garo E; Hoppe E; Barré B; Audran M; Bouvard B; Saint-André JP; Jeannin P
    PLoS Biol; 2012; 10(9):e1001395. PubMed ID: 23055831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis.
    Sato S; Chiba T; Nakahara T; Furue M
    Australas J Dermatol; 2020 Feb; 61(1):e39-e45. PubMed ID: 31424098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17/Th17 mediated synovial inflammation is IL-22 independent.
    van Hamburg JP; Corneth OB; Paulissen SM; Davelaar N; Asmawidjaja PS; Mus AM; Lubberts E
    Ann Rheum Dis; 2013 Oct; 72(10):1700-7. PubMed ID: 23328939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-36 cytokines are overexpressed in the skin and sera of patients with bullous pemphigoid.
    Maglie R; Mercurio L; Morelli M; Madonna S; Salemme A; Baffa ME; Quintarelli L; Di Zenzo GM; Antiga E; Albanesi C
    Exp Dermatol; 2023 Jun; 32(6):915-921. PubMed ID: 36940975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.
    Carrier Y; Ma HL; Ramon HE; Napierata L; Small C; O'Toole M; Young DA; Fouser LA; Nickerson-Nutter C; Collins M; Dunussi-Joannopoulos K; Medley QG
    J Invest Dermatol; 2011 Dec; 131(12):2428-37. PubMed ID: 21881584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
    Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
    Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
    Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
    J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.